-
In this small pilot study of patients who sought help for insomnia, most of the awakenings were actually caused by sleep-disordered breathing.
-
The FDA has approved a new drug with a novel mechanism of action for the treatment of rheumatoid arthritis in patients intolerant to or who have had inadequate response to methotrexate. Tofacifinib is an oral Janus kinase (JAK) inhibitor and is marketed by Pfizer as Xeljanz.
-
A randomized, controlled trial showed that moderate doses of simvastatin or pravastatin resulted in reduced energy or exertional fatigue in up to 40% of patients, especially in women.
-
This study does not support the hypothesis that high calcium intake increases coronary artery calcification
-
Sedentary time is associated with an increased risk of diabetes, cardiovascular disease, and cardiovascular and all-cause mortality.
-
Zoledronic Acid Treatment of Osteoporosis in Men; Relapsing Lyme Disease: Fact or Fiction?; Hypertension and Gout
-
Apixaban approval; new dental clinical practice guideline; apixaban for VTE; aspirin resistance; tamoxifen treatment; and FDA actions.
-
The ECG shown above was obtained from a 74-year-old woman who presented with abrupt onset of severe renal colic but no chest pain. Based on findings seen in her ECG, acute cardiac catheterization was performed. Her coronary arteries were normal on cath.
-
In a meta-analysis, investigators found that recent studies show no difference in the risk of catheter-related bloodstream infections between internal jugular, subclavian, and femoral sites. Older studies had a lower risk for the internal jugular site compared to the femoral site.
-
This study shows that as hospitals adopt electronic workflows, automatic triggering of a rapid response system based solely on changes in vital signs could place a tremendous burden on the system.
